Clinical trial
MEXWILS - Performance and Safety of MEX-CD1 Low-volume Continuous Veno-venous Haemodialysis Medical Device for Copper-extraction in Patients With Wilson's Disease
NCT05917327 is registered in ClinicalTrials.gov with Mexbrain as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MEXWILS - Performance and Safety of MEX-CD1 Low-volume Continuous Veno-venous Haemodialysis Medical Device for Copper-extraction in Patients With Wilson's Disease
- Lead sponsor
- Mexbrain
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 24, 2024
- Completion date
- September 15, 2025
- Enrollment
- 1 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
hepatolenticular degeneration; wilson